Parmax Pharma Ltd — Insider Trading, 30-12-2025: Insider Trading / SAST

Parmax Pharma Limited has announced the closure of the trading window for its Designated Persons, effective January 01, 2026. This closure is in anticipation of the upcoming financial results for the quarter ending December 31, 2025. The window will reopen 48 hours after these results are declared. The company will separately announce the date of the board meeting where these financial results will be considered. This signals that the company's quarterly earnings are due soon.